V
Velarion™Intelligence
Sign InFree TrialBook a Walkthrough
MedTech & Diagnostics

GE HealthCare Technologies Executive Compensation (FY25)

GEHC · Chicago, IL · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Peter Arduini
Latest say-on-pay support
=
May 7, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Member: every covered company in MedTech & Diagnostics, with dashboards, peer screens and board-ready briefs. Three seats, one year.
Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.

The paid brief on GE HealthCare Technologies

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
Data as of October 21, 2026Latest filing (8-K): May 11, 2026
7 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
GE HealthCare Technologies brief$1,500Get the executive brief
Velarion Member, one year
355 figures on this page: 351 cited to the filing that reported them, 4 calculated from figures it prints. See the citations

More on GE HealthCare Technologies

Five data products on this company. Each one is requested through the developer setup page.
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Peter Arduini: $19,487,880 → $18,562,794 (4.7% lower)
Say-on-pay support: 94.7% → 96.4% (1.7 points higher)
CEO pay ratio: 267:1 → 241:1 (9.7% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is GE HealthCare Technologies' chief executive and what were they paid?
Peter Arduini, President and CEO, received $18,562,794 in total compensation for fiscal 2025. Arduini's total was 4.7% lower than the $19,487,880 reported for fiscal 2024.
What was GE HealthCare Technologies' say-on-pay result?
The say-on-pay proposal drew 96.4% of votes cast for or against in favor at the meeting held May 7, 2026 for fiscal 2025.
Which companies are in GE HealthCare Technologies' peer group?
The disclosed peer group includes Abbott Laboratories, Agilent Technologies, Inc., Baxter International Inc., Becton, Dickinson and Company and Boston Scientific Corporation, among others.
What is GE HealthCare Technologies' chief executive pay ratio?
The disclosed chief executive pay ratio for fiscal 2025 is 241:1, against median employee compensation of $76,951.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Arduini
President and CEO
◇—◇◇◇—◇◇
Frank Jimenez
General Counsel and Corporate Secretary
◇—◇—◇—◇◇
Betty Larson
Chief People Officer
◇◇◇—◇—◇◇
Helmut Zodl
Chief Financial Officer
◇—◇—◇—◇◇
Jan Makela
President & CEO, Imaging
◇—◇—◇—◇◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Arduini
President and CEO
◇—◇◇◇◇◇◇
Taha Kass-Hout
Chief Science and Technology Officer
◇◇◇◇◇—◇◇
James Saccaro
VP and CFO
◇◇◇◇◇—◇◇
Frank Jimenez
General Counsel and Corporate Secretary
◇—◇◇◇—◇◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Arduini
President and CEO
◇—◇◇◇—◇◇
Taha Kass-Hout
Chief Science and Technology Officer
◇—◇◇◇—◇◇
James Saccaro
VP and CFO
◇—◇◇◇—◇◇
Frank Jimenez
General Counsel and Corporate Secretary
◇—◇◇◇—◇◇
Roland Rott
President and CEO, Imaging
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Peter Arduini
President and CEO
◇—◇◇◇◇◇◇
Taha Kass-Hout
Chief Science and Technology Officer
◇◇◇◇◇—◇◇
James Saccaro
VP and CFO
◇—◇◇◇—◇◇
Frank Jimenez
General Counsel and Corporate Secretary
◇—◇◇◇—◇◇
Jeannette Bankes
President and CEO, Patient Care Solutions
◇◇◇◇◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Frank JimenezOPTION◇——◇—◇◇
Frank JimenezPSU◇◇◇—◇—◇
Frank JimenezRSU◇——◇——◇
James SaccaroRSU◇——◇——◇
James SaccaroPSU◇◇◇—◇—◇
James SaccaroOPTION◇——◇—◇◇
Jeannette BankesRSU◇——◇——◇
Jeannette BankesPSU◇◇◇—◇—◇
Jeannette BankesRSU◇——◇——◇
Jeannette BankesOPTION◇——◇—◇◇
Peter ArduiniRSU◇——◇——◇
Peter ArduiniOPTION◇——◇—◇◇
Peter ArduiniPSU◇◇◇—◇—◇
Taha Kass-HoutRSU◇——◇——◇
Taha Kass-HoutPSU◇◇◇—◇—◇
Taha Kass-HoutOPTION◇——◇—◇◇
Fiscal 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Taha Kass-HoutRSU◇◇——
Option◇—◇2/1/2033
RSU◇◇——
RSU◇◇——
Option◇—◇3/3/2035
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇3/1/2033
Option◇—◇3/1/2034
James SaccaroOption◇—◇3/3/2035
RSU◇◇——
Option◇—◇6/1/2033
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇6/1/2033
Option◇—◇3/1/2034
Peter ArduiniRSU◇◇——
Option◇—◇3/1/2033
RSU◇◇——
Option◇—◇3/3/2035
RSU◇◇——
RSU◇◇——
Option◇—◇3/1/2034
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/1/2033
Frank JimenezRSU◇◇——
Option◇—◇3/3/2035
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇3/1/2033
RSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇2/1/2033
Option◇—◇3/1/2034
Jeannette BankesRSU◇◇——
RSU◇◇——
RSU◇◇——
Option◇—◇5/15/2035
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Frank Jimenez
General Counsel and Corporate Secretary · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
James Saccaro
VP and CFO · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Jeannette Bankes
President and CEO, Patient Care Solutions · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Peter Arduini
President and CEO · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇
Taha Kass-Hout
Chief Science and Technology Officer · Terms as described in the company’s compensation discussion · citing a 2026 filing
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Benefits continuation on change in control◇
Benefits continuation◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
H. Lawrence Culp Jr
◇◇————◇
Risa Lavizzo-Mourey
◇◇————◇
Catherine Lesjak
◇◇————◇
William J. Stromberg
◇◇———◇◇
Phoebe L. Yang
◇◇————◇
Tomislav Mihaljevic
◇◇————◇
Rodney F. Hochman
◇◇————◇
Anne T. Madden
◇◇————◇
Lloyd W. Howell Jr
◇◇————◇
Peter J. Arduini and Kevin A. Lobo served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Board chair premium◇
Lead independent director premium◇
Audit committee chair◇
Compensation committee chair◇
Nominating and governance chair◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Abbott Laboratories ABT
  • Agilent Technologies, Inc. A
  • Baxter International Inc. BAX
  • Becton, Dickinson and Company BDX
  • Boston Scientific Corporation BSX
  • Danaher Corporation DHR
  • Edwards Lifesciences Corporation EW
  • Hologic, Inc. HOLX
  • Intuitive Surgical, Inc. ISRG
  • Koninklijke Philips N.V. PHG
  • Medtronic plc MDT
  • Quest Diagnostics Incorporated DGX
  • Siemens Healthineers AG symbol not shown
  • Stryker Corporation SYK
  • Thermo Fisher Scientific Inc. TMO

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 7, 2026=◇◇◇
2024May 28, 2025=◇◇◇
2023May 21, 2024=◇◇◇
2022May 23, 2023=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Velarion Pro: every company page, peer tools and exports, one seat

One seat, one person. It opens the whole platform: the peer tools, the written analysis and the exports, on every company we cover. Join the list and you will hear from us when it opens.
Your address is used for this and nothing else, and you can unsubscribe in one click. See the privacy policy.

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Peter Arduini (President and CEO), FY2025 total compensation $18,562,794 (base salary $1,324,983) [exec_comp, SEC accession 0001932393-26-000021, filed 2026-03-19]

Answered within 24 hours, every figure cited to its SEC filing. If our database cannot answer your question, you are refunded automatically.

Tell me when GE HealthCare Technologies files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact GE HealthCare Technologies disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where GE HealthCare Technologies sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $1,500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $1,500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $499
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether GE HealthCare Technologies' disclosed peer group is defensible, who names GE HealthCare Technologies back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
355 figures on this page: 351 cited to the filing that reported them, 4 calculated from figures it prints.
351 cited to the filing
4 calculated from the filing

Documents cited

  1. 0001932393-26-000034
    5 2. Our stockholders approved our named executive officers’ compensation in an advisory vote, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes
  2. 0001932393-26-000021
    CEO Pay Ratio · Compensation Discussion and Analysis · Compensation Tables · Director Compensation · and 1 more section
  3. 0001932393-25-000032
    5 2. Our stockholders approved our named executive officers’ compensation in an advisory vote, based on the following voting results: Votes For Votes Against Abstentions Broker Non-Votes
  4. 0001628280-25-017240
    Compensation Tables
  5. 0001628280-24-024926
  6. 0001932393-23-000094
  7. 0001932393-23-000070
    Summary Compensation Table
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “GE HealthCare Technologies executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/GEHC (accessed 2026).
Short form: data: Velarion

The paid brief for GE HealthCare Technologies

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $499 for the board report; $2,400 for both.
Get the executive briefGet the board briefNo account needed.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about GE HealthCare Technologies and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers GE HealthCare Technologies discloses

The companies named in GEHC's own disclosed peer group.

Abbott LaboratoriesAgilent Technologies, Inc.Baxter International Inc.Becton, Dickinson and CompanyBoston Scientific CorporationDanaher CorporationEdwards Lifesciences CorporationHologic, Inc.Intuitive Surgical, Inc.Medtronic plcQuest Diagnostics IncorporatedStryker CorporationThermo Fisher Scientific Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy